Evidence map›Paper›PMID 38528610›Full record

ReviewJournal of medical case reports2024

Metastasis of serous ovarian carcinoma to the breast: a case report and review of the literature.

Sofia Dueño, Rachel Stein, Mohsin Jamal, Gregory Lewis, Karina Hew

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in Journal of medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sofia DueñoDepartment of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, FL, USA.
Rachel SteinDepartment of Radiology, University of Florida College of Medicine, Jacksonville, FL, USA.
Mohsin JamalDepartment of Molecular and Digital Pathology, University of Florida College of Medicine, Jacksonville, FL, USA.
Gregory LewisDivision of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, FL, USA.
Karina HewDivision of Gynecology Oncology, Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville, 653-1 West 8th Street, Jacksonville, FL, 32209, USA. karina.hew@jax.ufl.edu.
University of Florida · USFlorida College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast metastasis from primary ovarian cancer is rare, with an estimated frequency of 0.07%. More than 110 cases are reported in the literature of metastatic spread of ovarian cancer to the breast and axilla. This entity usually represents aggressive late disease characterized by multi-drug chemoresistance and a poor prognosis with a median survival time of 16 months. Currently no standardized treatment protocol exists for this condition. CASE PRESENTATION: We present a case of a 59-year-old Caucasian female with recurrent high-grade serous ovarian cancer who was diagnosed with symptomatic unilateral breast metastasis while on fourth line chemotherapy with weekly paclitaxel. She was treated with local radiation with 2300 cGy to the right breast with a complete response. She then had a subsequent recurrence in the ipsilateral breast 8 months after completion of post treatment imaging. She remains alive to date approximately 2 years after her initial diagnosis of breast metastasis on seventh line treatment.

conclusionsBreast metastasis from primary ovarian cancer is rare and represents advanced disease characterized by multi-drug chemoresistance and a poor prognosis. This case describes radiation therapy as a safe, effective treatment option to improve local control and quality of life in these patients, but with limited durability of response.

Indexed as

Breast NeoplasmsCystadenocarcinoma, SerousOvarian NeoplasmsFemaleHumansMiddle AgedPaclitaxelQuality of LifePaclitaxelBreast metastasisOvarian adenoarcinomaOvarian cancer

Identifiers

PMID38528610
PMCPMC10964545
OpenAlexW4394738163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.